Jan. 23 at 4:01 PM
$TMO "Heads up alert! Upcoming earnings on Thursday, 1/29/2026 for
$TMO
Bullish (8.0)
---
Financial Analysis of Thermo Fisher Scientific (TMO)
Thermo Fisher Scientific Inc.
(TMO) is positioned favorably within the life sciences sector, driven by its robust portfolio of products and services, particularly in specialty diagnostics and bioprocessing.
The company has demonstrated consistent revenue growth, with forecasts projecting a 3-6% increase for 2026 and 2027, potentially accelerating to over 7% in subsequent years.
As of the latest reports, TMO's trailing P/E ratio stands at approximately 35.07, while the forward P/E ratio is estimated at 24.51, indicating a premium valuation relative to its historical averages.
The earnings per share (EPS) growth is anticipated to remain positive, reflecting the company's strategic focus on high-demand markets such as personalized medicine and non-invasive diagnostics.
Recent strategic collaborations, including partnerships with NVIDIA for AI-driven lab automation, further bolster TMO's competitive edge.
Compared to industry peers, Thermo Fisher's solid position is underscored by a favorable return on equity (ROE) and operating margins that outpace many competitors in the life sciences tools sector.
---
Upcoming Earnings Report Expectations
Thermo Fisher is set to release its fourth-quarter earnings on January 29, 2026, with analysts expecting modest single-digit EPS growth.
The company's historical performance has been strong, often exceeding market expectations, which may lead to a positive market reaction.
Consensus estimates suggest a potential earnings surprise based on the company's track record and recent operational developments.
Analysts are closely monitoring the impact of TMO's recent acquisitions and product launches on revenue and margin trends, which could significantly influence investor sentiment in the days leading up to the earnings release.
---
Sector Performance Overview
The life sciences tools sector, to which Thermo Fisher belongs, has shown resilience amid broader market fluctuations.
This sector benefits from ongoing advancements in biotechnology and an increasing demand for diagnostic solutions, particularly in light of rising healthcare needs.
The overall industry is projected to maintain a growth rate of approximately 5%, supported by innovation in drug discovery and personalized medicine.
As healthcare continues to evolve, companies like Thermo Fisher are well-positioned to capitalize on emerging opportunities, reinforcing their role as leaders in the life sciences landscape.
- Funds were net buyers of
$TMO during the previous reporting quarter.
- Funds with large holdings in
$TMO include:
- Farallon Capital Management LLC, MV:
$610MM. Fund Rank: 69%
www.faralloncapital.com
- Cantillon Captal Management LLC, MV:
$420MM. Fund Rank: 77%
www.cantillon.com
- Ensign Peak Advisors, MV:
$387MM. Fund Rank: 74%
- Bluespruce Investment LP, MV:
$274MM. Fund Rank: 88%
- Adage Capital P, MV:
$261MM. Fund Rank: 86%
www.adagecapital.com
- Last 10 days performance: 3%
- Last 30 days performance: 11%
- Last 90 days performance: 11%
Some of the latest news articles:
- Title: Can Specialty Diagnostics Strength Drive Thermo Fisher's Q4 Earnings?
Publication Date: 1/23/2026 12:17:00 PM, Source: yahoo
URL: https://finance.yahoo.com/news/specialty-diagnostics-strength-drive-thermo-121700698.html?.tsrc=rss
- Title: Omics Lab Services: Global Market Review 2021-2025 and Forecast 2026-2031 Featuring Profiles of Agilent Technologies, Q2 Solutions, Flomics Biotech, QIAGEN, Thermo Fisher Scientific and More
Publication Date: 1/23/2026 11:35:00 AM, Source: yahoo
URL: https://finance.yahoo.com/news/omics-lab-services-global-market-113500565.html?.tsrc=rss
- Title:
$4.5 Billion Whole Genome Sequencing Market Outlook, 2031 Featuring Profiles of Illumina, Thermo Fisher Scientific, Oxford Nanopore Technologies and Other Leading Players
Publication Date: 1/23/2026 10:47:00 AM, Source: yahoo
URL: https://finance.yahoo.com/news/4-5-billion-whole-genome-104700373.html?.tsrc=rss
- Title: Thermo Fisher Scientific (TMO) Reports Next Week: Wall Street Expects Earnings Growth
Publication Date: 1/22/2026 3:00:17 PM, Source: yahoo
URL: https://finance.yahoo.com/news/thermo-fisher-scientific-tmo-reports-150017731.html?.tsrc=rss
Follow us on stocktwits.com for more earnings alerts. Not a financial advice. Not a trading signal."
